Cargando…
High-content microscopy reveals a morphological signature of bortezomib resistance
Drug resistance is a challenge in anticancer therapy, particularly with targeted therapeutics and cytotoxic compounds. In many cases, cancers can be resistant to the drug prior to exposure, i.e., possess intrinsic drug resistance. However, we lack target-independent methods to anticipate resistance...
Autores principales: | Kelley, M.E., Berman, A.Y., Stirling, D.R., Cimini, B.A., Han, Y., Singh, S., Carpenter, A.E., Kapoor, T.M., Way, G.P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187224/ https://www.ncbi.nlm.nih.gov/pubmed/37205516 http://dx.doi.org/10.1101/2023.05.02.539137 |
Ejemplares similares
-
High-content microscopy reveals a morphological signature of bortezomib resistance
por: Kelley, Megan E, et al.
Publicado: (2023) -
CellProfiler Analyst 3.0: accessible data exploration and machine learning for image analysis
por: Stirling, David R, et al.
Publicado: (2021) -
Pharmacovigilance of patients with multiple myeloma being treated with bortezomib and/or thalidomide
por: Castro, T.B.M., et al.
Publicado: (2016) -
Pipeline for illumination correction of images for high-throughput microscopy
por: Singh, S, et al.
Publicado: (2014) -
Bortezomib in mantle cell lymphoma: comparative therapeutic outcomes
por: Vallumsetla, Nishanth, et al.
Publicado: (2015)